| scholarly article | Q13442814 |
| P50 | author | Yuan Clare Zhang | Q73048876 |
| Xiao-Qin Wang | Q87971322 | ||
| Lan Wang | Q87971324 | ||
| P2093 | author name string | Yuan-Chao Tu | |
| P2860 | cites work | Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome | Q24200485 |
| Triptolide induces apoptotic death of T lymphocyte | Q77591555 | ||
| Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis | Q80110594 | ||
| [Study on the clinical application of wuzhi capsule after renal transplantation] | Q82112537 | ||
| Tripterygium wilfordii Hook F treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysis | Q83477523 | ||
| Remission of membranous nephropathy after therapy with Astragalus membranaceus | Q83908363 | ||
| Nephrotic syndrome | Q86858141 | ||
| Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy | Q86904633 | ||
| Co-administration of Wuzhi capsules and tacrolimus in patients with idiopathic membranous nephropathy: clinical efficacy and pharmacoeconomics | Q87634922 | ||
| Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus | Q46883330 | ||
| Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial | Q47241339 | ||
| Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506. | Q47703559 | ||
| Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial | Q47743844 | ||
| Effects of traditional chinese medicine Wuzhi capsule on pharmacokinetics of tacrolimus in rats | Q47762213 | ||
| Tetrandrine potentiates the glucocorticoid pharmacodynamics via inhibiting P-glycoprotein and mitogen-activated protein kinase in mitogen-activated human peripheral blood mononuclear cells | Q47832997 | ||
| Immunosuppressive efficacy of tetrandrine combined with methylprednisolone against mitogen-activated peripheral blood mononuclear cells of haemodialysis patients | Q48279332 | ||
| Effects of Wuzhi capsule on blood concentration of tacrolimus after renal transplantation | Q50220634 | ||
| Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial | Q50664664 | ||
| Minimal Change Disease. | Q52945061 | ||
| Identification of aristolochic acid in Chinese herbs. | Q55065510 | ||
| Rituximab for idiopathic membranous nephropathy | Q57703309 | ||
| [Effect of Tripterygium wilfordii on the remission of proteinuria in patients with nephrotic syndrome] | Q67282667 | ||
| In vitro immunosuppressive properties of the plant alkaloid tetrandrine | Q69823534 | ||
| M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy | Q24652978 | ||
| Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference | Q26995515 | ||
| Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis | Q30240107 | ||
| Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. | Q34431548 | ||
| Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking | Q35039049 | ||
| The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: a meta-analysis | Q35040896 | ||
| Pathobiochemistry of nephrotic syndrome | Q35079070 | ||
| Nephrotic syndrome in childhood. | Q35207868 | ||
| Developing traditional chinese medicine in the era of evidence-based medicine: current evidences and challenges | Q35531469 | ||
| Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders. | Q35743706 | ||
| Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study | Q35861417 | ||
| Herbal treatment for renal diseases. | Q36052168 | ||
| Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients | Q37211086 | ||
| Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy | Q37411651 | ||
| Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine | Q37522597 | ||
| Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome | Q37670299 | ||
| Pathogenesis of membranous nephropathy: recent advances and future challenges | Q37988806 | ||
| Childhood nephrotic syndrome--current and future therapies | Q38017937 | ||
| A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients. | Q38195900 | ||
| Causes and pathogenesis of focal segmental glomerulosclerosis | Q38275115 | ||
| Cost analysis on the use of rituximab and calcineurin inhibitors in children and adolescents with steroid-dependent nephrotic syndrome | Q38597096 | ||
| Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations. | Q38656144 | ||
| Emerging Agents for the Management of Nephrotic Syndrome: Progress to Date | Q38662074 | ||
| Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis. | Q38737314 | ||
| Tetrandrine--A molecule of wide bioactivity | Q38743106 | ||
| Diagnosis and Management of Nephrotic Syndrome in Adults | Q38775189 | ||
| Comparison of second-line immunosuppressants for childhood refractory nephrotic syndrome: a systematic review and network meta-analysis | Q38917805 | ||
| Minimal change disease and idiopathic FSGS: manifestations of the same disease. | Q38982416 | ||
| Toxicity of triptolide and the molecular mechanisms involved | Q39237694 | ||
| Treatment of membranous nephropathy: time for a paradigm shift | Q39410091 | ||
| Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. | Q39717376 | ||
| Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes | Q40167441 | ||
| Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients | Q40492205 | ||
| Preventing aristolochic acid nephropathy. | Q43132918 | ||
| Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract | Q45040917 | ||
| Refractory nephrotic syndrome | Q45120337 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | traditional Chinese medicine | Q200253 |
| nephrotic syndrome | Q504790 | ||
| P304 | page(s) | 8746349 | |
| P577 | publication date | 2018-01-04 | |
| P1433 | published in | Evidence-based Complementary and Alternative Medicine | Q5418319 |
| P1476 | title | Traditional Chinese Medicine for Refractory Nephrotic Syndrome: Strategies and Promising Treatments | |
| P478 | volume | 2018 |
| Q57099359 | Astragalus membranaceus (Fisch.) Bunge repairs intestinal mucosal injury induced by LPS in mice |
| Q90411908 | Chinese Herbal Injections for Primary Nephrotic Syndrome in Adults: A Systematic Review and Network Meta-Analysis |
| Q91742482 | Triptolide potentiates the cytoskeleton-stabilizing activity of cyclosporine A in glomerular podocytes via a GSK3β dependent mechanism |
Search more.